Casey B L, Ray C A, Piercey M F
Upjohn Company, Kalamazoo, MI, USA.
J Neural Transm (Vienna). 1996;103(3):277-85. doi: 10.1007/BF01271239.
(+)-AJ 76 is a stimulant dopamine (DA) antagonist, which has a putative preferential action at DA nerve terminal autoreceptors. Because it is both a mild stimulant and a DA antagonist, it has previously been suggested that (+)-AJ 76 might antagonize both the euphoria and craving associated with cocaine abuse and withdrawal, respectively. To evaluate this hypothesis further, (+)-AJ 76 was evaluated for its ability to affect cocaine-induced changes in regional brain energy metabolism. Using Sokoloff's 2-deoxyglucose autoradiographic technique, (+)-AJ 76 antagonized the stimulant effect of cocaine. Although classical DA antagonists are known to depress regional brain energy metabolism, (+)-AJ 76 by itself had no effect. It is concluded that the results are consistent with the previously stated hypothesis that (+)-AJ 76 might be useful as a pharmacotherapy for treatment of cocaine abuse.
(+)-AJ 76是一种刺激性多巴胺(DA)拮抗剂,它对DA神经末梢自身受体具有假定的优先作用。由于它既是一种轻度兴奋剂又是一种DA拮抗剂,此前有人提出(+)-AJ 76可能分别拮抗与可卡因滥用和戒断相关的欣快感和渴望。为了进一步评估这一假设,对(+)-AJ 76影响可卡因诱导的区域脑能量代谢变化的能力进行了评估。使用索科洛夫的2-脱氧葡萄糖放射自显影技术,(+)-AJ 76拮抗了可卡因的刺激作用。虽然已知经典的DA拮抗剂会抑制区域脑能量代谢,但(+)-AJ 76本身没有作用。得出的结论是,这些结果与之前提出的假设一致,即(+)-AJ 76可能作为治疗可卡因滥用的药物疗法有用。